<DOC>
	<DOC>NCT02294526</DOC>
	<brief_summary>Work hypothesis A diet rich in sardine will improve the metabolic control in type 2 diabetes patients.</brief_summary>
	<brief_title>A Sardine Diet Intervention Study to Assess Benefits to the Metabolic Profile in Type 2 Diabetes Mellitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Age &gt; 40 years and &lt; 85 BMI ≥ 25 and &lt; 35 Patients diagnosed with type 2 diabetes at onset or treated only by diet HbA1c between 6.0 and 8.0% (based on the last measured and documented laboratory measurement of the previous 3 months) Usual consumption ≤ 3 fish per week T2D treated with antidiabetic oral drugs and/or insulin Current or previous (within 3 months) intake of omega 3 suplements Known allergy or intolerance to fish or fish protein Diagnosis of active neoplasic disease Suffering from an acute illness which requires a recovery period higher than one week Currently chronic treatment with oral steroids or nonesteroidal antiinflammatory for more than 5 days, at least 1 month before randomization Pregnant or breastfeeding patients Serious acute vascular events (cardiac or cerebral) diagnosed previous 2 months before the randomization Current or previous (within 6 months) participation in another study Chronic renal insufficiency (creatinine &gt;1,5 mg/dl) Any conditions that the investigator considers may render the patient unable to complete the study During the interventional study, based on current standards of T2D care, doctors will introduce antidiabetic oral drugs or insulin into the patient's treatment, where they consider it to be necessary.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Diet</keyword>
	<keyword>Sardine</keyword>
	<keyword>Type 2 diabetes</keyword>
</DOC>